Michitaka Nagase

Randomized, Open-Label, Phase III Study Comparing Irinotecan With Paclitaxel in Patients With Advanced Gastric Cancer Without Severe Peritoneal Metastasis After Failure of Prior Combination Chemotherapy Using Fluoropyrimidine Plus Platinum: WJOG 4007 Trial

Shuichi Hironaka, Shinya Ueda, Hirofumi Yasui et al. · Journal of Clinical Oncology · 2013 · 559 citations

Medicine, Oncology, Pharmacology +10

Randomized phase III study of bevacizumab plus FOLFIRI and bevacizumab plus mFOLFOX6 as first-line treatment for patients with metastatic colorectal cancer (WJOG4407G)

K. Yamazaki, Michitaka Nagase, H Tamagawa et al. · Annals of Oncology · 2016 · 282 citations · Full text

Medicine, Oncology, Pharmacotherapy +8

Phase II feasibility study of preoperative chemotherapy with docetaxel, cisplatin, and fluorouracil for esophageal squamous cell carcinoma

Hiroki Hara, Makoto Tahara, Hiroyuki Daiko et al. · Cancer Science · 2013 · 213 citations · Full text

Medicine, Oncology, Surgery +12

Phase II Study of Radiotherapy Employing Proton Beam for Hepatocellular Carcinoma

Mitsuhiko Kawashima, Junji Furuse, Teiji Nishio et al. · Journal of Clinical Oncology · 2005 · 213 citations · Full text

Medicine, Oncology, Radiation Oncology +16

A Multi-center Retrospective Analysis of Survival Benefits of Chemotherapy for Unresectable Biliary Tract Cancer

Naohiro Yonemoto, J. Furuse, T. Okusaka et al. · Japanese Journal of Clinical Oncology · 2007 · 89 citations · Full text

Medicine, Oncology, Pharmacology +13